Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer
Proceedings of the National Academy of Sciences · 25.07.2023 · 120 (30)
DOI: 10.1073/pnas.2220296120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.07.2023. Verfasst von Boqiang Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, MicroRNAs. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China.
Abstract (Originalsprache)
Metastasis, especially intrahepatic, is a major challenge for hepatocellular carcinoma (HCC) treatment. Cytoskeleton remodeling has been identified as a vital process mediating intrahepatic spreading. Previously, we reported that HCC tumor adhesion and invasion were modulated by circular RNA (circRNA), which has emerged as an important regulator of various cellular processes and has been implicated in cancer progression. Here, we uncovered a nuclear circRNA, circASH2, which is preferentially lost in HCC tissues and inhibits HCC metastasis by altering tumor cytoskeleton structure. Tropomyosin 4 (TPM4), a critical binding protein of actin, turned out to be the major target of circASH2 and was posttranscriptionally suppressed. Such regulation is based on messenger RNA (mRNA)/precursormRNA splicing and degradation process. Furthermore, liquid–liquid phase separation of nuclear Y-box binding protein 1 (YBX1) enhanced by circASH2 augments TPM4 transcripts decay. Together, our data have revealed a tumor-suppressive circRNA and, more importantly, uncovered a fine regulation mechanism for HCC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.
- Zhejiang Provincial Key Laboratory of Laparoscopic Technology, Zhejiang University, Hangzhou 310016, China.
- Zhejiang Minimal Invasive Diagnosis and Treatment Technology Research Center of Severe Hepatobiliary Disease, Hangzhou 310016, China.
- Zhejiang Research and Development Engineering Laboratory of Minimally Invasive Technology and Equipment, Hangzhou 310016, China.
- Department of Endocrinology, The Children's Hospital, School of Medicine, National Clinical Research Center for Child Health, Zhejiang University, Hangzhou 310053, China.
- Department of Diagnostic Ultrasound & Echocardiography, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.
ORCID-Profile: Boqiang Liu, Xiujun Cai
Förderung
- MOST | National Natural Science Foundation of China
Zitieren
APA
Liu, B., Shen, H., He, J., Jin, B., Tian, Y., Li, W., Hou, L., Zhao, W., Nan, J., Zhao, J., Shen, J., Yu, H., Wang, Y., Shan, G., Shi, L., & Cai, X. (2023). Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer. Proceedings of the National Academy of Sciences, 120(30). https://doi.org/10.1073/pnas.2220296120
Vancouver
Liu B, Shen H, He J, Jin B, Tian Y, Li W, et al. Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer. Proceedings of the National Academy of Sciences. 2023;120(30). doi:10.1073/pnas.2220296120
BibTeX
@article{Liu2023,
author = {Liu, Boqiang and Shen, Hao and He, Jing and Jin, Binghan and Tian, Yuanshi and Li, Weiqi and Hou, Lidan and Zhao, Weijun and Nan, Junjie and Zhao, Jia and Shen, Jiliang and Yu, Hong and Wang, Yifan and Shan, Ge and Shi, Liang and Cai, Xiujun},
title = {Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {30},
doi = {10.1073/pnas.2220296120}
}
EUVIMED